BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20641087)

  • 1. Evaluating the clinical usefulness of structured questions in parosmia assessment.
    Landis BN; Frasnelli J; Croy I; Hummel T
    Laryngoscope; 2010 Aug; 120(8):1707-13. PubMed ID: 20641087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Euosmia: a rare form of parosmia.
    Landis BN; Frasnelli J; Hummel T
    Acta Otolaryngol; 2006 Jan; 126(1):101-3. PubMed ID: 16308262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on the prognostic significance of qualitative olfactory dysfunction.
    Reden J; Maroldt H; Fritz A; Zahnert T; Hummel T
    Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):139-44. PubMed ID: 17006637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and correlates of parosmia and phantosmia among smell disorders.
    Pellegrino R; Mainland JD; Kelly CE; Parker JK; Hummel T
    Chem Senses; 2021 Jan; 46():. PubMed ID: 34698820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia.
    Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T
    Laryngoscope; 2024 Apr; ():. PubMed ID: 38578016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of non-conductive olfactory disorders in eastern Austria: a study of 120 patients from the Department of Otorhinolaryngology at the University of Vienna.
    Quint C; Temmel AF; Schickinger B; Pabinger S; Ramberger P; Hummel T
    Wien Klin Wochenschr; 2001 Jan; 113(1-2):52-7. PubMed ID: 11233469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and associated factors of qualitative olfactory dysfunction.
    Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH
    Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distorted odorant perception: analysis of a series of 56 patients with parosmia.
    Bonfils P; Avan P; Faulcon P; Malinvaud D
    Arch Otolaryngol Head Neck Surg; 2005 Feb; 131(2):107-12. PubMed ID: 15723940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of olfactory dysfunction.
    Hummel T; Lötsch J
    Arch Otolaryngol Head Neck Surg; 2010 Apr; 136(4):347-51. PubMed ID: 20403850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and assessment of qualitative olfactory dysfunction in different age groups.
    Nordin S; Murphy C; Davidson TM; Quiñonez C; Jalowayski AA; Ellison DW
    Laryngoscope; 1996 Jun; 106(6):739-44. PubMed ID: 8656960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of odor hedonic perception: the Sniffin' sticks parosmia test (SSParoT).
    Liu DT; Welge-Lüssen A; Besser G; Mueller CA; Renner B
    Sci Rep; 2020 Oct; 10(1):18019. PubMed ID: 33093474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of parosmia: the Skövde population-based studies.
    Nordin S; Brämerson A; Millqvist E; Bende M
    Rhinology; 2007 Mar; 45(1):50-3. PubMed ID: 17432070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain lesion-pattern analysis in patients with olfactory dysfunctions following head trauma.
    Lötsch J; Ultsch A; Eckhardt M; Huart C; Rombaux P; Hummel T
    Neuroimage Clin; 2016; 11():99-105. PubMed ID: 26937377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Signs and symptoms, etiologies and clinical course of parosmia + in a series of 84 patients].
    Portier F; Faulcon P; Lamblin B; Bonfils P
    Ann Otolaryngol Chir Cervicofac; 2000 Feb; 117(1):12-8. PubMed ID: 10671709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of postviral qualitative olfactory dysfunction using the short SSParoT in patients with and without parosmia.
    Sekine R; Menzel S; Hähner A; Mori E; Hummel T
    Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):469-472. PubMed ID: 36006515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation of qualitative olfactory dysfunction.
    Frasnelli J; Landis BN; Heilmann S; Hauswald B; Hüttenbrink KB; Lacroix JS; Leopold DA; Hummel T
    Eur Arch Otorhinolaryngol; 2004 Aug; 261(7):411-5. PubMed ID: 14610680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
    Mueller A; Reuner U; Landis B; Kitzler H; Reichmann H; Hummel T
    Mov Disord; 2006 Sep; 21(9):1311-6. PubMed ID: 16763975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parosmia and Neurological Disorders: A Neglected Association.
    Ciurleo R; De Salvo S; Bonanno L; Marino S; Bramanti P; Caminiti F
    Front Neurol; 2020; 11():543275. PubMed ID: 33240192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-infectious olfactory loss: a cohort study and update.
    Rombaux P; Martinage S; Huart C; Collet S
    B-ENT; 2009; 5 Suppl 13():89-95. PubMed ID: 20084809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative smell/taste disorders as sequelae of acute COVID-19.
    Ercoli T; Masala C; Pinna I; Orofino G; Solla P; Rocchi L; Defazio G
    Neurol Sci; 2021 Dec; 42(12):4921-4926. PubMed ID: 34557966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.